Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial

Exclusion Criteria

• •Any current or past history or risk for tuberculosis:
• •Active tuberculosis requiring treatment within the previous 3 years. All participants will be required to have a QuantiFERON tuberculosis Gold or T-SPOT tuberculosis test performed at screening. Also excluded are participants with evidence of a past tuberculosis infection without documented adequate therapy. Participants with a positive QuantiFERON tuberculosis Gold or T-SPOT tuberculosis test at screening will not be eligible for the study. A QuantiFERON tuberculosis Gold or T-SPOT tuberculosis test performed within 4 weeks of dosing on Day 1 is acceptable as long as there is documentation of a negative result.
• •Current clinical, radiographic, or laboratory evidence of active tuberculosis
• •A history of herpes zoster